A national programme to scale-up decentralised hepatitis C point-of-care testing and treatment in Australia

Lancet Gastroenterol Hepatol. 2023 Mar;8(3):204-207. doi: 10.1016/S2468-1253(22)00355-7.
No abstract available

MeSH terms

  • Australia / epidemiology
  • Hepacivirus / genetics
  • Hepatitis C* / diagnosis
  • Hepatitis C* / drug therapy
  • Hepatitis C* / epidemiology
  • Humans
  • Point-of-Care Testing